HER2DX: a tool that might inform treatment choices for HER2-positive breast cancer. Hurvitz SA. Lancet Oncol 2020;21:1392-1393.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hurvitz SA. HER2DX: a tool that might inform treatment choices for HER2-positive breast cancer. Lancet Oncol 2020;21:1392-1393.
PMID: 33152281